SynerFuse_Header Image.png
 

SynerFuse™ Announces New Strategic Advisors

MINNEAPOLIS – May 24, 2021 – SynerFuse, Inc., a Minneapolis-based medical device company, is pleased to announce the addition of new strategic advisors to the SynerFuse team, bringing clinical, economic, and executive management experience to the company.

In addition to previously announced advisors Jeannine Rivet and Tim Skaja, SynerFuse welcomes aboard its newest advisors:

  • Tom Schreier (Chair of Allina Health, Director, PiperSandler)

  • Jeff Fritz (Former CEO, Revel (Icario Health), Evolution1 (WEX Health))

  • Mike Finch, PhD. (Research Projects and Analytics Manager, Children’s MN)

  • A.R. Weiler (CEO, SonarMD)

  • Mehul J Desai, MD, MPH (Pain Medicine and Physical Medicine & Rehabilitation, International Spine, Pain & Performance Center)

  • Brian Oliver (former CEO, Global Tel Link)

About Chronic Lower Back Pain (CLBP)

CLBP is defined as pain that continues for 12 weeks or longer, even after an initial injury or underlying cause of acute lower back pain has been treated. With 500,000 procedures performed annually, spinal fusion remains a common treatment for spinal instability, albeit with a high incidence of residual neuropathic pain. The continuum of increasingly ineffective opioid treatments, additional interventions, and adjacent level spinal fusions leave up to 46% of patients with significant, lingering pain, costing the US healthcare system $20B per year and significantly affecting the quality of life of patients.

About SynerFuse
SynerFuse is a Delaware corporation based in Minnesota—the heart of Medical Alley. SynerFuse believes that individuals with chronic back pain and their providers deserve a better option than spinal fusion alone. Even when spinal fusion is successful, it can often result in residual chronic pain and use of addictive opioids. The company is working to create a new future of non-narcotic pain management for lower back pain with a patented therapy that integrates spinal fusion hardware, an active neuromodulation system, and sensors in a novel "smart" device.